Novartis continues to build healthcare talent ecosystem; announces BioCamp 2019
BioCamp engages students around scientific advances to address unmet medical needs and entrepreneurial opportunities
Offers ~50 post-graduate students insights in to the pharmaceutical industry through direct interaction with experts
Helps draw top talent to the healthcare industry
Mumbai, July 17, 2019– Novartis today announced the next edition of Novartis Biotechnology Leadership Camp (BioCamp) taking place in Hyderabad from October 13 to 16, 2019. Now in its 11th year, BioCamp has attracted top talent from across faculties to the healthcare industry thus contributing to the ecosystem.
“BioCamp provides top talent in the country the opportunity to understand trends, challenges and opportunities in the pharmaceutical industry. We believe these insights help them envision the role they can play in influencing the course of healthcare in the country through their career choices, while providing a talent pipeline to the industry,” says Sanjay Murdeshwar, Country President, Novartis in India.
BioCamp is part of the Novartis commitment to supporting the exchange of ideas and thoughts between young talent in science and business and the Company. It is designed to provide students with a platform to collaborate across faculties and interact with thought leaders who lead the company’s unique approach to address patients’ unmet medical needs. The program is open to postgraduate students and young researchers in natural sciences, medicine, biotechnology, bio-informatics, pharmacy, business administration, chartered accountancy or law (specialization in Intellectual Property Rights) interested in pursuing a career in the pharmaceutical industry. Interested students should visit https://www.novartis.in/careers/biocamp or email [email protected] for more information.
Previous speakers include Dr. Alok Srivastava, Professor Hematology – CMC, Vellore; Arijit Sarker, Director, Google India; Prof. K. Srinath Reddy, President, Public Health Foundation of India (PHFI); Padma Shri Dr. A. S. Soin, Chief Hepatobiliary and Liver Transplant Surgeon; Kiran Mazumdar-Shaw, Chairperson & Managing Director, Biocon Limited, G. V. Prasad, CoChairman & CEO, Dr Reddy’s Laboratories Limited among others.
The jury will select three individual winners and one winning team based on their contribution, performance, leadership and teamwork. Novartis India has introduced around 500 top students to the pharmaceutical industry and entrepreneurship since launching BioCamp in 2009.
Launched in 2004 in Taiwan, BioCamp has developed into a forum for science and business students from around the country to learn, exchange ideas and work together in a highly competitive business environment. BioCamp has been held annually in India since 2009. Students go through a rigorous judging process before they are selected to participate in the event. Around 50 students from diverse faculties including pharmacology, biotechnology, life sciences, finance, biomedical engineering, genetics, business management and immunology participated last year. Institutes they came from in the past included the Indian Institutes of Technology, Kharagpur and Bombay; Indian School of Business, Hyderabad and Mohali;
XLRI, Jamshedpur; BITS Pilani; NMIMS, Mumbai; JIPMER, Pondicherry; St. Xavier’s College, Mumbai; Indian Statistical Institute Kolkata; Bombay College of Pharmacy; Symbiosis Institute of Management, Pune; National Institute of Immunology, Delhi; St. John’s Medical College, Bengaluru; Institute of Chemical Technology, Mumbai; Miranda House, Delhi; Kasturba Medical College, Manipal; Welingkar Institute of Management Development & Research among others.
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 750 million people globally and we are finding innovative ways to expand access to our latest treatments. About 105,000 people of more than 140 nationalities work at Novartis around the world. Find out more at www.novartis.com.
Novartis has a significant footprint in India with a strong drug development, manufacturing, commercial and services presence in the country. We have a rich portfolio of both innovative and established medicines to meet the medical needs of patients in India. Our social business – Arogya Parivar – is expanding access to community education, improved infrastructure and affordable healthcare products for underserved populations in rural India. About 8,000 fulltime employees work at Novartis pan India with the majority based out of Hyderabad, Kalwe and Mumbai. Find out more at www.novartis.in